Skip to content

Orphan Drugs: EMA’s COMP April 2013 Meeting Results

April 26, 2013

EMA’s Committee for Orphan Medicinal Products (COMP) held a meeting April 16 – 17, 2013. The EMA COMP April 2013 Meeting Report on the review of applications for orphan designation is published April 25, 2013. At this meeting, there are 11 positive opinions recommending orphan designation for the treatment of :

  1. Graft-Versus-Host Disease
  2. B-Cell Acute Lymphoblastic Leukemia
  3. Non-Dystrophic Myotonia
  4. Adrenocortical Carcinoma
  5. 5q Spinal Muscular Atrophy
  6. Adenosine Deaminase-Deficient Severe Combined Immunodeficiency
  7. Cytomegalovirus Disease
  8. Malignant Mesothelioma
  9. Cystic Fibrosis
  10. Retinitis Pigmentosa
  11. Transglutaminase-1-Deficient Autosomal Recessive Congenital Ichthyosis.

2013 EMA COMP Calendar

  1. May 14 – 15, 2013
  2. June 11 – 12, 2013
  3. July 9 – 10, 2013
  4. September 3 – 4, 2013
  5. October 8 – 9, 2013
  6. November 5 – 6, 2013
  7. December 10 – 11, 2013.

Please Note: “Purple Check” by Rocket000 [Public domain] | Wikimedia Commons.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: